MedPath

Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Phase 1
Conditions
Neurogenic Bladder
Interventions
Drug: tamsolusin
Registration Number
NCT00602186
Lead Sponsor
Tabriz University
Brief Summary

The purpose of this study is to determine whether Tamsolusin or Prazosin are effective in the treatment of female voiding dysfunction(BOO)

Detailed Description

Voiding dysfunction is not uncommon in Tabriz.About 20% of patients in female urology clinic of Tabriz university of medical sciences sufered from some degrees of voiding dysfunction (due to bladder imparement or bladder outlet obstruction).There is limited information about medical treatment of those patients. On the other hand alpha adrenergic blockers are the first choice medication in BENIGN PROSTATIC HYPERPLASIA. There is some new facts about destribution of alpha adrenergic blockers in female pelvic floor.The purpose of this study is to comparision whether Tamsolusin 0.4/daily or Prazosin 1 mg/daily are effective in the treatment of female voiding dysfunction(BOO)

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Healthy females with voiding difficulty with MFR<12 and post void residual urine>50cc
Exclusion Criteria
  • History of pelvic floor surgury during last 3 month
  • Any contraindication for Tamsolusin or prazosin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1tamsolusintaking Tamsulosin
2prazosintaking prasosin
Primary Outcome Measures
NameTimeMethod
patient symptoms improvement(Standard questionare)every month untile 3 months
Secondary Outcome Measures
NameTimeMethod
Urodynamics parameters improvementthree months later
© Copyright 2025. All Rights Reserved by MedPath